Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SetPoint Medical

Explore full profile

Developing novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease and multiple sclerosis

Santa Clarita, United StatesFounded 2006Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2025
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SetPoint Medical and the history behind them.

About SetPoint Medical

SetPoint Medical is a pioneering startup operating in the healthcare sector, specifically focusing on the treatment of chronic autoimmune diseases. The company has developed a unique treatment approach called Neuroimmune Modulation, which leverages advances in immunology, neuroscience, and bioengineering. This innovative method uses targeted electrical stimulation to regulate inflammation and restore immunologic balance in the body, offering a potential solution for patients suffering from chronic autoimmune conditions.

SetPoint Medical's business model revolves around the development and commercialization of their proprietary platform. Their primary clients are patients with chronic autoimmune diseases, a market that is continually expanding due to the increasing prevalence of these conditions. The company generates revenue through the sale of their medical devices and related services.

The startup is committed to evidence-based treatment advancement, underpinned by robust clinical research. This commitment is reflected in their team, which boasts expertise across medical devices, pharmaceuticals, and consumer technology. However, it's important to note that the company's device is currently classified as investigational and is limited by United States law to investigational use.

In summary, SetPoint Medical is a promising startup with a novel approach to treating chronic autoimmune diseases. Their unique blend of immunology, neuroscience, and bioengineering could potentially revolutionize the way these conditions are managed, offering hope to millions of patients worldwide.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2006
Headquarters
Santa Clarita, United States
Employees
120
Open positions
2
Dealroom signal
59.2/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
b2c

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Aug 2025 $115M $460M Boston Scientific · Morgenthaler Ventures · ShangBay Capital · Abbott ↗
SERIES COther financing Jul 2025 $25M $400M Undisclosed ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

SetPoint Medical website traffic

Latest recorded traffic for SetPoint Medical is 12K monthly website visits, up 64.4% over the last three months. SetPoint Medical's team grew 33.3% over the past year.

Latest monthly visits12K 3-month web change+64.4% 1-year team growth+33.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

26 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later24 investors entered at this stage

  • Boston Scientific
  • Morgenthaler Ventures
  • GSK
  • Action Potential Venture Capital
  • ShangBay Capital
  • Euclidean Capital
  • Beach Point Capital Management
  • SVE Capital
  • CITA Investissement
  • Midas Capital
  • Revelation Partners
  • Catalio Capital Management
  • Ascendum Capital
  • Runway Growth Capital
  • Norwest Venture Partners
  • TopSpin
  • Gilmartin Capital
  • Viking Global Investors
  • Richard King Mellon Foundation
  • Ally Bridge Group
  • Elevage Medical Technologies
  • Abbott
  • Northwell Health
  • SPRIG Equity

Other known investors1 additional known investor

  • Feinstein Institutes for Medical Research
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.8%
🇨🇳 China1.2%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SetPoint Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SetPoint Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.